FDA accepts Regeneron's sBLA for Eylea HD in RVO with priority review; QUASAR data supports monthly dosing, target action date set for August 2025.

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Winners of Westfair Business Journal's 2025 Millennial & Gen Z Awards . Photo by Diana Vollaro SOUTH NORWALK – When ...